You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for Patent: 5,116,863


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,116,863
Title: Dibenz[b,e]oxepin derivative and pharmaceutical compositions thereof
Abstract:Novel dibenz[b,e]oxepin derivatives are employed in the treatment and control of allergic conditions such as allergic asthma and also employed in the treatment of inflammation.
Inventor(s): Oshima; Etsuo (Shizuoka, JP), Kumazawa; Toshiaki (Shizuoka, JP), Otaki; Shizuo (Shizuoka, JP), Obase; Hiroyuki (Shizuoka, JP), Ohmori; Kenji (Mishima, JP), Ishii; Hidee (Shizuoka, JP), Manabe; Haruhiko (Shizuoka, JP), Tamura; Tadafumi (Shizuoka, JP), Shuto; Katsuichi (Shizuoka, JP)
Assignee: Kyowa Hakko Kogyo Co., Ltd. (Tokyo, JP)
Application Number:07/020,900
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent 5,116,863

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,116,863

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan61-45676Mar 03, 1986

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.